SF3B1 and B-cell chronic lymphocytic leukemia: In 2011, SF3B1 mutations were identified in hematological malignancies including myelodysplastic syndromes (MDS) and chronic lymphocytic leukemia (CLL) using next-generation sequencing [25–30].